Docoh
Loading...

ITOS ITeos Therapeutics

APP
Utility
2-OXO-THIAZOLE Derivatives As A2A Inhibitors and Compounds for Use In the Treatment of Cancers
1 Jul 21
Stefano Crosignani, Bruno Gomes, Erica Houthuys
Filed: 14 Aug 20
GRANT
Utility
2-oxo-thiazole derivatives as A2A inhibitors and compounds for use in the treatment of cancers
4 May 21
Stefano Crosignani, Bruno Gomes, Erica Houthuys
Filed: 14 Mar 19
GRANT
Utility
Combinations comprising a pyrrolidine-2,5-dione IDO1 inhibitor and an anti-body
16 Mar 21
Combinations of an IDO1 inhibitor (e.g., a 3-(5-fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione compound), with an anti-PD1 antibody or anti-PD-L1 antibody, and an anti-4-1BB antibody, as selected anti-cancer or anti-viral agents are provided.
Manfred Kraus, Sandra Cauwenberghs, Stefano Crosignani, Gregory Driessens
Filed: 12 May 16
APP
Utility
Thiocarbamate Derivatives As A2A Inhibitors, Pharmaceutical Composition Thereof and Combinations with Anticancer Agents
11 Mar 21
Stefano Crosignani, Paul Dickinson, Marcel de Matas, Erica Joke Katelijne Heleen Houthuys, Reece Gerrad Marillier, Chiara Martinoli, Olivier De Henau, Gregory Driessens
Filed: 9 Sep 20
APP
Utility
Anti-tigit Antibodies
30 Dec 20
Anti-TIGIT antibodies and antigen binding fragments thereof that inhibit TIGIT-mediated signalling are provided, together with combinations comprising said antibodies or antigen binding fragments thereof and methods for their use.
Anthony Cooper, Christophe Queva, Sofie Denies, Catherine Hoofd, Julia Cuende, Gregory Driessens, Florence Lambolez
Filed: 25 Jul 18
  • 1
Patents are sorted by USPTO publication date, most recent first